Evidence map›Paper›PMID 35710794›Full record

ArticleNature communications2022

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.

Theodore P Braun, Mariam Okhovat, Cody Coblentz, Sarah A Carratt, Amy Foley, Zachary Schonrock, Brittany M Curtiss, Kimberly Nevonen, Brett Davis, Brianna Garcia and 18 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Theodore P BraunKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0002-6248-2143
Mariam OkhovatKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Cody CoblentzKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Sarah A CarrattKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0003-2493-6789
Amy FoleyKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Zachary SchonrockKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Brittany M CurtissKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Kimberly NevonenKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0003-0198-1624
Brett DavisKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0001-7985-1921
Brianna GarciaKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Dorian LaTochaKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Benjamin R WeederProgram in Molecular and Cellular Biology, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0002-4128-5861
Michal R GrzadkowskiComputational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Joey C EstabrookComputational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Hannah G ManningComputational Biology Program, Oregon Health & Science University, Portland, OR, 97239, USA.
Kevin Watanabe-SmithKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Sophia JengDivision of Bioinformatics and Computational Biology, Oregon Health & Science University, Portland, OR, 97239, USA.
Jenny L SmithClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Amanda R LeontiClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Rhonda E RiesClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Shannon McWeeneyKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0001-8333-6607
Cristina Di GenuaMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.
Roy DrissenMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.ORCID http://orcid.org/0000-0002-8574-5014
Claus NerlovMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DS, UK.ORCID http://orcid.org/0000-0002-0544-735X
Soheil MeshinchiClinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.
Lucia CarboneKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, 97239, USA.
Brian J DrukerKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0001-8331-8206
Julia E MaxsonKnight Cancer Institute, Oregon Health & Science University, Portland, OR, 97239, USA. maxsonj@ohsu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35710794
PMCPMC9203537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.